Company intelligence / Profile preview

Uniquity Bio

King of Prussia, Pennsylvania, United Statesuniquity.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Uniquity Bio, launched in May 2024 with $300 million from Blackstone Life Sciences, focuses on developing novel medicines for immune-mediated diseases. Its lead program, solrikitug—an anti‑TSLP monoclonal antibody in‑licensed from Merck—is entering Phase II trials for asthma and COPD. The company leverages a leadership team with deep immunology expertise and a business model designed to rapidly advance high-potential assets through clinical development and partnerships. Early data from Merck de-risks the program; no new clinical results have been published by Uniquity as of May 2025[3][6][7].

Therapeutic areas: PulmonologyImmunology
Modalities: monoclonal antibodies (mAbs)
Industry: Biotech

Drug pipeline

3 assets

solrikitug

2 more assets in the full pipeline.

Request access →

Partnerships

Blackstone Life Sciences (capital partner/investor)[3]In-license agreement with Merck for solrikitug asset [3]

Beyond the preview

Go deeper on Uniquity Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uniquity Bio.

Explore the full profile